You are not logged in.

Changes in intravenous fluid use patterns in Australia and New Zealand: evidence of research translating into practice

Glassford, Neil J., French, Craig J., Bailey, Michael, Mârtensson, Johan, Eastwood, Glenn M. and Bellomo, Rinaldo 2016, Changes in intravenous fluid use patterns in Australia and New Zealand: evidence of research translating into practice, Critical care and resuscitation, vol. 18, no. 2, pp. 78-88.

Attached Files
Name Description MIMEType Size Downloads

Title Changes in intravenous fluid use patterns in Australia and New Zealand: evidence of research translating into practice
Author(s) Glassford, Neil J.
French, Craig J.
Bailey, Michael
Mârtensson, Johan
Eastwood, Glenn M.
Bellomo, Rinaldo
Journal name Critical care and resuscitation
Volume number 18
Issue number 2
Start page 78
End page 88
Total pages 11
Publisher College of Intensive Care Medicine of Australia and New Zealand
Place of publication Prahran, Vic.
Publication date 2016-06
ISSN 1441-2772
Keyword(s) Administration, Intravenous
Australia
Colloids
Female
Fluid Therapy
Humans
Isotonic Solutions
Male
New Zealand
Retrospective Studies
Translational Medical Research
Summary OBJECTIVES: To describe changes in the use of intravenous (IV) fluid by quantity and type in different regions of Australia and New Zealand.

DESIGN, SETTING AND PARTICIPANTS: We conducted a retrospective ecological study examining regional and temporal trends in IV fluid consumption across Australia and New Zealand over the periods 2012-2013 and 2013- 2014, using national proprietary sales data as a surrogate for consumption, and demographic data from the public domain.

RESULTS: More than 13.3 million litres of IV fluid were consumed in Australia and New Zealand in 2012-2013, and more than 13.9 million litres in 2013-2014, with colloid solutions accounting for < 2%. There was marked regional variation in consumption of fluids, by volumes and proportions used, when standardised to overall Australian and New Zealand values. There was no significant change in the overall volume of crystalloid solutions consumed but there was a significant decrease (9%; P = 0.02) in the ratio of unbalanced to balanced crystalloid solutions consumed. Consumption of all forms of colloid solutions decreased, with a 12% reduction overall (P = 0.02), primarily driven by a 67% reduction in the consumption of hydroxyethyl starch (HES) solutions.

CONCLUSIONS: The amount and type of IV fluid use, as determined by fluid sales, is highly variable across Australia and New Zealand. However, overall use of balanced crystalloid solutions is increasing and the use of HES has decreased dramatically.
Language eng
Field of Research 110399 Clinical Sciences not elsewhere classified
1103 Clinical Sciences
Socio Economic Objective 929999 Health not elsewhere classified
HERDC Research category C1 Refereed article in a scholarly journal
ERA Research output type C Journal article
Copyright notice ©2016, College of Intensive Care Medicine of Australia and New Zealand
Persistent URL http://hdl.handle.net/10536/DRO/DU:30085641

Document type: Journal Article
Collections: School of Nursing and Midwifery
Open Access Checking
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 5 times in TR Web of Science
Scopus Citation Count Cited 3 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 18 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Wed, 24 Aug 2016, 11:42:28 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.